1002-17: Novel Experimental Medicine Approaches to Depressive and Trauma-related Disorders

This session will enable the learner to improve their knowledge and skills related to psychiatric nursing care for persons with treatment-resistant depression, PTSD and anxiety.

Presenter: Sanjay J. Mathew, MD

Disclosures: The presenter serves as consultant to the following companies: Acadia, Alkermes, Allergan, Cerecor, Otsuka and Valeant. Research support from Janssen Research & Development for a clinical trial. Discussion of off-label uses (using products for a purpose other than that for which it was approved by the Food and Drug Administration, or FDA) occur in this presentation.

Session Length: 1 hour 20 minutes

Target Audience: RN, APRN 

Session Objectives:
Upon completion of this presentation, the participant will be able to:

1. Identify unmet needs in psychopharmacology of depressive/anxiety/trauma disorders.
2. Examine rationale for glutamate system therapeutics.
3. Discuss glutamate modulation beyond ketamine.
4. Describe opiate receptor targets.

Keywords: Depression, Ketamine, Pharmacology, Novel Drugs

Continuing Nursing Education
1.50 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the post test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Originally Presented
APNA 15th Annual Clinical Psychopharmacology Institute
Hyatt Regency Baltimore on the Inner Harbor
Friday, June 9, 2017
8:00am – 9:30am

The contact hours for this session expire: July 1, 2019